Mukherjee Regimen for Avascular Necrosis
I cannot provide information about the "Mukherjee regimen" as this specific treatment protocol is not mentioned or described in any of the available evidence, including the 2022 ACR Appropriateness Criteria guidelines or recent research literature on avascular necrosis of the femoral head.
What the Evidence Does Show for Early-Stage AVN Treatment
The available guidelines and research discuss several established approaches for early-stage (precollapse) avascular necrosis, but none reference a "Mukherjee regimen":
Noninvasive Therapies
- Limited supporting data exists for noninvasive treatments including statins, bisphosphonates, anticoagulants, extracorporeal shock wave therapy, and hyperbaric oxygen 1
- These conservative approaches have shown variable results in recent systematic reviews 2
Invasive Joint-Preserving Procedures
- Core decompression remains the primary surgical intervention for ARCO stages I-II (early precollapse stages) 1, 3
- Core decompression can be supplemented with autologous bone marrow cells, vascular fibular grafting, or electrical stimulation 1
- The overall efficacy of core decompression at preventing eventual articular collapse remains controversial 1
Emerging Therapies
- Stem cell therapy shows promise in preclinical studies with improvements in osteogenesis and angiogenesis, though hip survivorship benefits remain unproven 4
- Extracellular vesicles from stem cells represent a newer investigational approach 5
Important Caveat
If you encountered the term "Mukherjee regimen" in clinical practice or literature, please verify the original source, as it may be:
- A regional or institutional protocol not widely published
- A misattribution or alternative name for an established treatment
- Referenced in literature not captured in this evidence base
The 2022 ACR guidelines represent the most current, comprehensive approach to AVN management and do not reference this specific regimen 1.